The use of anabolic androgenic steroids and polypharmacy: A review of the literature

Drug and Alcohol Dependence

Volumn 114, Issue 2-3, 2011, Pages 100-109

  Dodge, Tonya ^a   Hoagland, Margaux F ^a  

^a SKIDMORE COLLEGE   (United States)

Author keywords

Anabolic steroids; Dietary supplements; Drug use; Performance enhancing substances; Polypharmacy

Indexed keywords

ALCOHOL; ANABOLIC AGENT; CANNABIS; ILLICIT DRUG; LEGAL PERFORMANCE ENHANCING SUBSTANCE; UNCLASSIFIED DRUG;

ALCOHOLISM; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; DRUG MISUSE; HUMAN; POLYPHARMACY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TOBACCO;

ALCOHOL DRINKING; ANABOLIC AGENTS; ANDROGENS; DIETARY SUPPLEMENTS; DOPING IN SPORTS; HUMANS; PERFORMANCE-ENHANCING SUBSTANCES; POLYPHARMACY; STEROIDS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

CANNABIS; NICOTIANA TABACUM;

EID: 79952702208     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.11.011     Document Type: Review

References (38)

1. Bahrke M.S., Yesalis C.E., Kopstein A.N., Stephens J.A. Risk factors associated with anabolic-androgenic steroid use. Sports Med. 2000, 29:397-405.
2. Beel A., Maycock B., McClean N. Current perspectives on anabolic steroids. Drug Alcohol Rev. 1998, 17:87-103.
3. Bolding G., Sherr L., Elford J. Use of anabolic steroids and associated health risks among gay men attending London gyms. Addiction 2002, 97:195-203.
4. Buckman J.F., Yusko D.A., White H.R., Pandina R.J. Risk profile of male college athletes who use performance-enhancing substances. J. Stud. Alcohol Drugs 2009, 70:919-922.
5. Büttner A., Thieme D. Side effects of anabolic androgenic steroids: pathological findings and structure-activity relationships. Handb. Exp. Pharmacol. 2010, 195:459-484.
6. Choi P.Y.L., Pope H.G. Violence toward women and illicit androgenic-anabolic steroid use. Ann. Clin. Psychiatry 1994, 6:21-25.
7. Dodge T.L., Jaccard J.J. The effect of high school sports participation on the use of performance-enhancing substances in young adulthood. J. Adolesc. Health 2006, 39:367-373.
8. Denham B.E. Association between narcotic use and anbolic-androgenic steroid use among American adolescents. Subst. Use Misuse 2009, 44:2043-2061.
9. DuRant R.H., Escobedo L.G., Heath G.W. Anabolic-steroid use, strength training, and multiple drug use among adolescents in the United States. Pediatrics 1995, 96:23-28.
10. Hoffman J.R., Faigenbaum A.D., Ratamess N.A., Ross R., Kang J., Tenenbaum G. Nutritional supplementation and anabolic steroid use in adolescents. Med. Sci. Sports Exerc. 2007, 40:15-24.
11. Kanayama G., Cohane G.H., Weiss R.D., Pope H.G. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an unrecognized problem. J. Clin. Psychiatry 2003, 64:156-160.
12. Kanayama G., Pope H.G., Cohane G., Hudson J.I. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend. 2003, 71:77-86.
13. Kanayama G., Barry S., Hudson J.I., Pope H.G. Body image and attitudes toward male roles in anabolic-androgenic steroid users. Am. J. Psychiatry 2006, 163:697-703.
14. Kanayama G., Boynes M., Hudson J.I., Field A.E., Pope H.G. Anabolic steroid abuse among teenage girls: An illusory problem?. Drug Alcohol Depend. 2007, 88:156-162.
15. Kanayama G., Hudson J.I., Pope H.G. Features of men with anabolic-androgenic steroid dependence: a comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend. 2009, 102:130-137.
16. Kartakoullis N.L., Phellas C., Pouloukas S., Petrou M., Loizou C. The use of anabolic steroids and other prohibited substances by gym enthusiasts in Cyprus. Int. Rev. Sociol. Sport 2008, 43:271-287.
17. Kindlundh A.M.S., Isacson D.G.L., Berglund L., Nyberg F. Factors associated with adolescent use of doping agents: anabolic-androgenic steroids. Addiction 1999, 94:543-553.
18. Kokkevi A., Fotiou A., Chileva A., Nociar A., Miller P. Daily exercise and anabolic steroids use in adolescents: a cross-national European study. Subst. Use Misuse 2008, 43:2053-2065.
19. Laure P., Binsinger C. Doping prevalence among preadolescent athletes: a four-year follow-up. Br. J. Sports Med. 2007, 41:660-663.
20. Luetkemeier M.J., Bainbridge C.N., Walker J., Brown D.B., Eisenman P.A. Anabolic-androgenic steroids: prevalence, knowledge, and attitudes in junior and senior high school students. J. Health Educ. 1995, 26:4-9.
21. McCabe S.E., Brower K.J., West B.T., Nelson T.F., Wechsler H. Trends in non-medical use of anabolic steroids by U.S. college students: Results from four national surveys. Drug Alcohol Depend. 2007, 90:243-251.
22. Meilman P.W., Crace R.K., Presley C.A., Lyerla R. Beyond performance enhancement: polypharmacy among collegiate users of steroids. J. Am. Coll. Health 1995, 44:98-104.
23. Miller K.E., Barnes G.M., Sabo D., Melnick M.J., Farrell M.P. Anabolic-androgenic steroid use and other adolescent problem behaviors: rethinking the male athlete assumption. Sociol. Perspect. 2002, 45:467-489.
24. Miller K.E., Barnes G.M., Sabo D., Melnick M.J., Farrell M.P. A comparison of health risk behavior in adolescent users of anabolic-androgenic steroids, by gender and athlete status. Sociol. Sport J. 2002, 19:385-402.
25. Miller K.E., Hoffman J.H., Barnes G.M., Sabo D., Melnick M.J., Farrell M.P. Adolescent anabolic steroid use, gender, physical activity, and other problem behaviors. Subst. Use Misuse 2005, 40:1637-1657.
26. Nieminen M.S., Rämö M.P., Viitasalo M., Heikkilä P., Karjalainen J., Mäntysaari M., Heikkilä J. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur. Heart J. 1996, 17:1576-1583.
27. Nilsson S., Spak F., Marklund B., Baigi A., Allebeck P. Attitudes and behaviors with regards to androgenic anabolic steroids among male adolescents in a county of Sweden. Subst. Use Misuse 2005, 40:1-12.
28. Pallesen S., Jøsendal O., Johnsen B., Larsen S., Molde H. Anabolic steroid use in high school students. Subst. Use Misuse 2006, 41:1705-1717.
29. Papadopoulos F.C., Skalkidis I., Parkkari J., Petridou E. Doping use among tertiary education students in six developed countries. Eur. J. Epidemiol. 2006, 21:307-313.
30. Pedersen W., Wichstrøm L. Adolescents, doping agents, and drug use: a community study. J. Drug Issues 2001, 31:517-542.
31. Salas-Ramirez K., Montalto P.R., Sisk C.L. Anabolic steroids have long-lasting effects on male social behaviors. Behav. Brain Res. 2010, 208:328-335.
32. Santora L.J., Marin J., Vangrow J., Minegar C., Robinson M., Mora J., Friede G. Coronary calcification in body builders using anabolic steroids. Prev. Cardiol. 2006, 9:198-201.
33. Striegel H., Simon P., Frisch S., Roecker K., Dietz K., Dickhuth H.H., Ulrich R. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. Drug Alcohol Depend. 2009, 81:11-19.
34. Sullivan M.L., Martinez C.M., Gallagher E.J. Atrial fibrillation and anabolic steroids. J. Emerg. Med. 1999, 17:851-857.
35. Thompson P.D., Zmuda J.M., Catlin D.H. Use of anabolic steroids among adolescents. N. Engl. J. Med. 1993, 329:888-889.
36. Wichstrøm L. Predictors of future anabolic androgenic steroid use. Med. Sci. Sports Exerc. 2006, 38:1578-1583.
37. Wichstrøm L., Pedersen W. Use of anabolic-androgenic steroids in adolescence: winning, looking good or being bad?. J. Stud. Alcohol 2001, 62:5-13.
38. Anabolic Steroids in Sport and Exercise 2000, Human Kinetics, Champaign, IL. C.E. Yesalis (Ed.).